Increasing Analyst Coverage, Conference Participation and Media Exposure

Following a successful uplisting to Nasdaq, this pharmaceutical company was challenged with minimal trading volume, a declining share price and minimal research coverage and media exposure.

Strategy & Tactics
  • We contacted analysts, conferences, business/financial and trade media to create positive exposure among investors and other key stakeholders.
  • We reached out to analysts to gain greater visibility for the stock.
  • Invitations to major industry conferences were secured.
  • In the first six months, the company presented at 5 industry specific conferences.
  • The company secured business/financial and trade media coverage.
  • The company received analyst coverage and secured financing of more than $27MM.